Multiple-Dose Safety and Pharmacokinetics of Oral Garenoxacin in Healthy Subjects

Garenoxacin (T-3811ME, BMS-284756) is a novel des-F(6) quinolone that has been shown to be effective in vitro against a wide range of clinically important pathogens, including gram-positive and gram-negative aerobes and anaerobes. This study was conducted to evaluate the safety and tolerability of m...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Gajjar, D. A., Bello, A., Ge, Z., Christopher, L., Grasela, D. M.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 2003
Teme:	Pharmacology
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC161848/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12821477/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.7.2256-2263.2003
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!